Evidence map›Paper›PMID 37090451›Full record

ArticlePharmacy practice

Association between COVID-19 symptoms, COVID-19 vaccine, and somatization among a sample of the Lebanese adults.

Antonio Nehme, Muna Barakat, Diana Malaeb, Sahar Obeid, Souheil Hallit, Georges Haddad

Open access · diamondAbstract read
In one paragraph

Article in Pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Antonio NehmeSchool of Medicine and Medical Sciences, Holy Spirit University of Kaslik, P.O. Box 446, Jounieh, Lebanon. antonio.j.nehme@net.usek.edu.lb.ORCID https://orcid.org/0000-0002-2805-3222
Muna BarakatDepartment of Clinical Pharmacy and therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, 11931, Jordan. m_barakat@asu.edu.jo.ORCID https://orcid.org/0000-0002-7966-1172
Diana MalaebCollege of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates. Dr.diana@gmu.edu.ae.ORCID https://orcid.org/0000-0002-2436-850X
Sahar ObeidSocial and Education Sciences Department, School of Arts and Sciences, Lebanese American University, Jbeil, Lebanon. saharobeid23@hotmail.com.ORCID https://orcid.org/0000-0002-0735-4704
Souheil HallitSchool of Medicine and Medical Sciences, Holy Spirit University of Kaslik, P.O. Box 446, Research Department, Psychiatric Hospital of the Cross, Jal Eddib, Lebanon. souheilhallit@hotmail.com.ORCID https://orcid.org/0000-0001-6918-5689
Georges HaddadSchool of Medicine and Medical Sciences, Holy Spirit University of Kaslik, P.O. Box 446, Psychiatry Departments, Psychiatric Hospital of the Cross, Jal Eddib, Lebanon. georgeshaddad.hpc@gmail.com.ORCID https://orcid.org/0000-0002-2981-4572
Holy Spirit University of Kaslik · LBApplied Science Private University · JOGulf Medical University · AELebanese American University · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Long COVID syndrome, the poorly defined illness, has been increasingly mentioned in recent studies yet is still poorly understood especially when it comes to precipitating and modulating factors, the high prevalence of mental health problems associated with the COVID-19 pandemic has brought to light the hypothesis of the existence of a psychological component associated with the persistence of symptoms and if vaccination may serve as a modulating factor. This study aims to examine the prevalence of somatization disorders and association between persistent COVID-19 symptoms and COVID-19 vaccine with somatization among a sample of the Lebanese general population. Methods: A cross-sectional study was carried out between September and October 2021. The snowball sampling technique was picked to choose a sample that addressed all Lebanese Mohafazat. Patient Health Questionnaire-15 (PHQ-15) was used to assess somatization. Results: A total of 403 participants was enrolled in this study, with a mean age of 32.76 ± 13.24 years, 108 (26.8%) had medium somatization symptoms (PHQ-15 scores ≥10). Having persistent COVID symptoms (β=2.15) was significantly associated with more somatization, whereas the intake of COVID vaccine (β=-1.17) was significantly associated with less somatization. Conclusion: Long lasting COVID-19 symptoms were closely related to somatization, although the administration of the COVID-19 vaccine was associated with less somatization. However, further studies are needed to provide a better understanding of the relationship between long COVID and somatization, on one hand, and the modulating factors on the other hand.

Indexed as

COVID 19COVID persistent symptomsLebanonsomatizationsomatoform disordersvaccine

Identifiers

PMID37090451
PMCPMC10117341
OpenAlexW4362665537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.